# EDGAR Filing Document

**Accession Number:** 0001533998
**File Stem:** 0001140361-25-026782
**Filing Date:** 2025-7
**Character Count:** 8786
**Document Hash:** be785d0a726e994d8ae5ea6fd518e744
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001140361-25-026782.hdr.sgml**: 20250722

**ACCESSION NUMBER**: 0001140361-25-026782

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13G

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250722

**DATE AS OF CHANGE**: 20250722

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** DarioHealth Corp.
- **CENTRAL INDEX KEY:** 0001533998
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 452973162
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-88306
- **FILM NUMBER:** 251141189

**BUSINESS ADDRESS:**
- **STREET 1:** 322 W 57TH ST. #33B
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10019
- **BUSINESS PHONE:** 972-4-770-6377

**MAIL ADDRESS:**
- **STREET 1:** 322 W 57TH ST. #33B
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10019

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LabStyle Innovations Corp.
- **DATE OF NAME CHANGE:** 20111101
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Titan Trust 2024 I
- **CENTRAL INDEX KEY:** 0002050526

**ORGANIZATION NAME:**
- **EIN:** 996319820
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G

**BUSINESS ADDRESS:**
- **STREET 1:** WILMINGTON SAVINGS FUND SOCIETY FSB
- **STREET 2:** 500 DELAWARE AVE, FL 11TH
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19801
- **BUSINESS PHONE:** 213-441-2679

**MAIL ADDRESS:**
- **STREET 1:** WILMINGTON SAVINGS FUND SOCIETY FSB
- **STREET 2:** 500 DELAWARE AVE, FL 11TH
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19801

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13G

### Under the Securities Exchange Act of 1934

**Issuer:** DarioHealth Corp.

**Title of Class of Securities:** Common Stock, par value $0.0001 per share

**CUSIP Number:** 23725P209

**Date of Event Which Requires Filing of this Statement:** 06/09/2025

**Check the appropriate box to designate the rule pursuant to which this Schedule is filed:**

- [ ] Rule 13d-1(b)

- [x] Rule 13d-1(c)

- [ ] Rule 13d-1(d)

---

| 1. | Names of Reporting Persons<br>Titan Trust 2024 I | Names of Reporting Persons<br>Titan Trust 2024 I |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>2500100 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>2500100 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>0 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>2500100 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>2500100 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>5.32% | Percent of Class Represented by Amount in Row (9)<br>5.32% |
| 12. | Type of Reporting Person (See Instructions)<br>OO | Type of Reporting Person (See Instructions)<br>OO |

**Comment for Type of Reporting Person:** Row 5, Row 7 and Row 9 represent 2,500,100 shares of common stock of the Issuer issuable under a warrant dated February 15, 2024 exercisable within 60 days after June 9, 2025 that is directly held by the Reporting Person. The percentage ownership reported in Row 11 was calculated based on a denominator that is the sum of  44,463,781 shares of Common Stock outstanding as of May 29, 2025, as reported in the Issuer's Proxy Statement for its Annual Meeting of Stockholders filed with the Securities and Exchange Commission (SEC) on May 30, 2025, plus the 2,500,100 shares reported hereby in Rows 5, 7 and 9.

---

**Item 1(a). Name of Issuer:**
DarioHealth Corp.

**Item 1(b). Address of Issuer's Principal Executive Offices:**
322 W. 57th Street, # 33B, New York, New York, 10019

**Item 2(a). Name of Person Filing:**
Titan Trust 2024 I

**Item 2(b). Address of Principal Business Office:**
c/o WhiteHawk Capital Partners LP, as Administrator 
11601 Wilshire Blvd., Suite 1980, Los Angeles, CA, 90025

**Item 2(c). Citizenship:**
Titan Trust 2024 I is a Delaware statutory trust organized under the laws of the State of Delaware.

**Item 2(d). Title of Class of Securities:**
Common Stock, par value $0.0001 per share

**Item 2(e). CUSIP Number:**
23725P209

**Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:**

(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e) [ ] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f) [ ] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g) [ ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) [ ] A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), if filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

(k) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

**Item 4. Ownership:**

**(a) Amount beneficially owned:**

2,500,100 shares of Common Stock of the Issuer. WhiteHawk Capital Partners LP ("WhiteHawk"), as the Administrator of Titan Trust 2024 I pursuant to a Trust Agreement dated February 15, 2024, may be deemed to beneficially own the securities reported herein. The filing of this Schedule 13G shall not be construed as an admission that WhiteHawk is, for the purposes of sections 13(d) or 13(g) of the Act, the beneficial owner of any securities covered hereby.

**(b) Percent of class:**

5.32%

**(c) Number of shares as to which the person has:**

**(i) Sole power to vote or to direct the vote:**

2,500,100

**(ii) Shared power to vote or to direct the vote:**

0

**(iii) Sole power to dispose or to direct the disposition of:**

2,500,100

**(iv) Shared power to dispose or to direct the disposition of:**

0

**Item 5. Ownership of Five Percent or Less of a Class.**

[x] If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.

**Item 6. Ownership of More than 5 Percent on Behalf of Another Person.**

Not Applicable

**Item 7. Identification and Classification of the Subsidiary**

Not Applicable

**Item 8. Identification and Classification of Members of the Group**

Not Applicable

**Item 9. Notice of Dissolution of Group**

Not Applicable

**Item 10. Certification:**

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Titan Trust 2024 I**

**Date:** 07/22/2025

**By:** By: WhiteHawk Capital Partners LP Its Administrator /s/ Robert Louzan

**Name & Title:** Robert Louzan/Managing Partner